植物疫苗市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00024327
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

植物疫苗市场规模预计将从 2023 年的 14.4 亿美元增至 2031 年的 39.6 亿美元。预计 2023-2031 年市场复合年增长率为 13.5%。增加产品发布和产品批准可能仍然是市场的主要趋势。

植物疫苗市场分析

植物疫苗研发活动数量的增加导致产品批准和上市,加上传染病流行率的不断上升,预计将推动植物疫苗市场的增长。此外,研究活动的资金增加和技术进步预计将有助于市场增长。此外,植物疫苗产品的进步,例如农杆菌基因转移和基因工程植物病毒转化是生产有效疫苗的两种典型方法,预计将在未来几年创造充足的机会。

植物疫苗市场概述

植物疫苗研发活动数量的增加导致产品批准和上市,加上传染病流行率的不断上升,预计将推动植物疫苗市场的增长。此外,由于产品推出、产品批准数量不断增加以及研发活动的刺激,北美将在 2023 年占据主要市场份额。欧洲是继北美和亚太地区之后的第二大地区,由于研究的不断发展和传染病的日益流行,植物疫苗市场的需求猛增,预计将出现显着的增长率。由于制药行业的不断发展,澳大利亚、印度和韩国等国家预计将提供各种增长机会,这是推动市场增长的因素。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

植物疫苗市场:

植物疫苗市场

  • 年均复合增长率(2023 - 2031)
    13.5%
  • 2023 年市场规模
    14.4 亿美元
  • 2031 年市场规模
    39.6 亿美元

市场动态

增长动力
  • 植物疫苗的研发活动数量不断增加
未来的趋势
  • 传染病的日益流行创造了对植物疫苗的需求
机会
  • 植物疫苗生产的进步创造了利润丰厚的增长机会

关键人物;主力;重要一员

  • 梅迪卡戈公司
  • 英美烟草公司
  • 图标遗传学有限公司
  • 创意生物实验室有限公司
  • iBio公司
  • 莱尼奥比奥
  • 流明生物科学公司
  • 叶表达系统有限公司
  • ZYUS生命科学有限公司
  • 夫琅和费CMB

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

疫苗类型
  • 细菌疫苗
  • 病毒疫苗
  • 寄生虫疫苗
  • 植物源性病毒样颗粒
来源
  • 烟草厂
  • 玉米
  • 土豆
应用
  • 流感
  • 寨卡病毒
  • 伊波拉病毒
  • 家禽疾病
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

植物疫苗市场驱动因素和机遇

传染病发病率上升有利于市场

COVID-19、流感、普通感冒、结核病 (TB)、甲型肝炎和乙型肝炎等传染病的流行率不断上升,预计将在预测期内旺盛对植物疫苗的需求。 2019 年 12 月 31 日,中国武汉首次发现一例 COVID-19 病例。 2020 年 3 月 11 日,世界卫生组织宣布 COVID-19 为大流行病。 COVID-19 的迅速扩散给世界各地的医疗保健系统带来了挑战。许多国家的医院和重症监护病房 (ICU) 不堪重负或濒临崩溃。因此,需要最有效地利用医疗资源。由于呼吸设备、熟练的重症监护人员或受保护的患者监测系统的使用有限,医疗保健提供者被迫治疗病情危重的患者。防止 COVID-19 患者病情恶化和进入 ICU 的努力是巨大的。为了减缓 SARS-CoV-2 病毒的传播并防止未来爆发,非常需要新的诊断、治疗和疫苗接种。

植物疫苗生产的进展

在基于植物的疫苗接种技术中,使用各种方法将编码特定疾病的抗原蛋白的所需基因整合到植物组织的基因组中。通过农杆菌进行基因转移和通过基因工程植物病毒进行转化是生产有效疫苗的两种典型方法。然而,随着科学技术的进步,人们创造了新的方法来提高旧技术的效率,包括生物射弹、电穿孔、农杆菌渗透、超声处理和聚乙二醇处理。当微生物基因整合到植物基因组中时,它们会被翻译成目标病原体蛋白抗原,而不会伤害植物或失去其免疫原性。全身和粘膜免疫反应参与启动宿主针对感染的免疫。一些疫苗,例如霍乱、莱姆病、炭疽、破伤风、鼠疫、轮状病毒和犬细小病毒,是使用直接轰击或生物射弹方法进行的。结核病、登革热、禽流感和埃博拉疫苗是使用间接方法或农杆菌介导的基因转移开发的。

植物疫苗市场报告细分分析

有助于植物疫苗市场分析的关键部分是疫苗类型、来源和应用。

  • 根据疫苗类型,植物疫苗市场分为细菌疫苗、病毒疫苗、寄生虫疫苗、植物源病毒样颗粒(VLPS)等。 2023 年,细菌疫苗领域占据最大的市场份额。
  • 按来源划分,市场分为烟草、玉米、马铃薯等。 2023 年,烟草植物领域占据最大的市场份额。
  • 从应用来看,市场分为流感、寨卡病毒、埃博拉病毒、家禽疾病、Covid-19等。 2023 年,流感细分市场占据重要市场份额。

按地域划分的植物疫苗市场份额分析

植物疫苗市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲以及南美洲和中美洲。

由于产品推出数量的增加以及研发活动的刺激,北美占据了市场主导地位。然而,在预测期内,市场可能会受到产品批准相关挑战以及植物疫苗生产的污染和环境风险等因素的限制。美国是全球最大的植物疫苗市场。该市场的增长归因于该国在植物疫苗领域开展的大量研发活动。该地区传染病流行率的上升预计将增加对植物疫苗的需求。病毒性肝炎、流感和结核病 (TB) 等感染仍然是美国疾病和死亡的主要原因之一,导致在感染相关并发症上花费大量资金。预计亚太地区未来几年将以最高的复合年增长率增长。

植物疫苗市场报告范围

报告属性细节
2023年市场规模14.4亿美元
2031 年市场规模39.6亿美元
全球复合年增长率(2023 - 2031)13.5%
历史数据2021-2022
预测期2024-2031
涵盖的细分市场按疫苗类型
  • 细菌疫苗
  • 病毒疫苗
  • 寄生虫疫苗
  • 植物源性病毒样颗粒
按来源
  • 烟草厂
  • 玉米
  • 土豆
按申请
  • 流感
  • 寨卡病毒
  • 伊波拉病毒
  • 家禽疾病
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 梅迪卡戈公司
  • 英美烟草公司
  • 图标遗传学有限公司
  • 创意生物实验室有限公司
  • iBio公司
  • 莱尼奥比奥
  • 流明生物科学公司
  • 叶表达系统有限公司
  • ZYUS生命科学有限公司
  • 夫琅和费CMB
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

植物疫苗市场新闻和最新动态

植物疫苗市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下列出了植物疫苗市场的一些发展:

  • Medicago 和葛兰素史克 (GSK) 宣布加拿大卫生部已批准 COVIFENZ COVID-19 疫苗(基于植物的病毒样颗粒 [VLP],重组,佐剂)。该疫苗适用于 18 至 64 岁个体进行主动免疫,预防由严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 引起的 2019 年冠状病毒病 (COVID-19)。 (来源:葛兰素史克,新闻稿,2022 年 2 月)
  • CEPI 向 LenioBio 提供高达 200 万美元的资金,以提供临床前概念验证,即商业上可用的、基于植物的无细胞技术可以生产用于 20 年内针对流行病和大流行威胁的疫苗试验的蛋白质。 40天。使用 LenioBio 的 ALiCE 技术,其目标是减少用细胞培养等“更传统的方法”生产疫苗蛋白所需的时间。 (来源:CEPI,时事通讯,2024 年 5 月)

植物疫苗市场报告范围和可交付成果

《植物疫苗市场规模和预测(2021-2031)》报告对以下领域的市场进行了详细分析:

  • 植物疫苗市场规模以及全球、区域和国家层面涵盖的所有关键细分市场的预测
  • 植物疫苗市场趋势以及市场动态,例如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 植物疫苗市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,包括市场集中度、热图分析、知名参与者以及植物疫苗市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the Plant based vaccines market in 2023?

North America region dominated the Plant based vaccines market in 2023

What are the driving factors impacting the Plant based vaccines market?

Increasing number of research and development activities in plant-based vaccines leads to product approval and launches along with growing prevalence of infectious disease are the driving factors impacting the Plant based vaccines market

What are the future trends of the Plant based vaccines market?

Increasing product launches and product approvals are the future trends of the Plant based vaccines market

Which are the leading players operating in the Plant based vaccines market?

The leading players operating in the Plant based vaccines market includes MEDICAGO, INC., British American Tobacco p.l.c., ICON GENETICS GMBH, CREATIVE BIOLABS, INC., iBio, Inc., LENIOBIO, Lumen Bioscience, Inc., LEAF EXPRESSION SYSTEMS LTD., ZYUS LIFE SCIENCES INC., FRAUNHOFER CMB

What would be the estimated value of the Plant based vaccines market by 2031?

The estimated value of the Plant based vaccines market by 2031 is US$ 3.96 Bn

What is the expected CAGR of the Plant based vaccines market?

The expected CAGR of the Plant based vaccines market is 13.5%

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports